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Acute pancreatitis is a common disease leading to hospitalizations, most often caused by gallstones or alcohol. We present a case of
a patient diagnosed with acute pancreatitis considered to be due to loperamide treatment for diarrhea.
1. Case Report
A 58-year-old woman with a history of hypertension,
hypothyroidism, and cholecystectomy presented to the emer-
gency department with a 7-day history of abdominal pain,
nausea, and vomiting. The pain started after she began to
take loperamide for diarrhea. She started having diarrhea 10
days before admission and took loperamide for two days,
10mg on the first day and then 6mg on the second day.
Her daily medications were thyroxin, hydrochlorothiazide,
and atenolol. She did not drink alcohol or smoke. At initial
clinical examination, she had normal vital parameters (blood
pressure, pulse, oxygen saturation, respiration rate, and tem-
perature) and palpation tenderness in epigastrium. She had
elevated lipase 2513U/L (normal < 300U/L) and amylase
124U/L (normal < 120U/L).WBCwas 12,5mmol/L and CRP
was 63mg/L. Hemoglobin, electrolytes, arterial blood gas,
creatinine, urea, and liver functions tests including bilirubin
were within normal limits. Abdominal CT scan showed the
status after cholecystectomy and acute pancreatitis (Figure 1).
MRCP showed the status after cholecystectomy, diameter of
the common bile duct was 5mm, and there were no signs of
gallstones. Her calcium level was 2,22mmol/L.
Loperamide was discontinued, her condition improved
rapidly, and she was discharged three days after her
admission. The patient has not suffered further attacks of
pancreatitis and is doing well approximately 12 months after
her hospitalization.
2. Discussion
Acute pancreatitis is a common disease leading to hospital-
ization, with incidence figures ranging from 14.6 to 32 per
100.000 [1, 2]. Inmost series, the vastmajority of patients have
gallstones- or alcohol-induced pancreatitis. Drug-induced
pancreatitis is relatively rare [3]; however, 525 different drugs
are listed in theWorld Health Organization (WHO) database
suspected to cause acute pancreatitis as a side effect. Many of
them are widely used to treat highly prevalent diseases. The
true incidence is not entirely clear since only few systematic
population-based studies exist [4]. In a recent cohort study,
3,4% of the patients had drug-induced pancreatitis [3]. Some
drugs have pancreatitis documented as a side effect such as
azathioprine [5], and opiates have also been shown to lead to
pancreatitis in most series investigating this [3–5].
Loperamide, a peripheral acting opiate [6], has very rarely
been associated with pancreatitis. The first case report on
this possible association, published in French, described a
57-year-old woman with a history of a cholecystectomy, who
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Figure 1: A computed tomography scan at the day of admission
showing pancreatitis changes.
had taken 4mg of loperamide therapeutically and presented
2 hours later with lower abdominal pain and an elevated
amylase that normalized in several days. Her abdominal pain
resolved spontaneously within several hours [7]. From this
first report, pancreatitis has been reported in 2 cases to be
due to loperamide overdose [8, 9]. An 18-year-oldwomanhad
taken an overdose of loperamide and presented an hour later
with elevated lipase and amylase, which normalized within
24 hours. Abdominal ultrasound was normal [8]. Lee et al.
reported a previously healthy 17-year-old woman who had
taken an overdose of loperamide and presented 2 hours later
with mild abdominal pain and elevated lipase and amylase.
Abdominal ultrasound and computed tomography showed
a normal pancreas. She recovered spontaneously [9]. All the
previously reported cases have revealed normal pancreas on
ultrasound or abdominal CT scan. However, in the current
case, the abdominal CT scan showed clearly inflamed pan-
creas (Figure 1). Our patient came to the hospital one week
after she became symptomatic, but in the other published
cases the patient presented after few hours.
Loperamide is a synthetic agonist of peripheral opiate
receptors and used in treatment of diarrhea [6]. The effect
on diarrhea is primarily due to an inhibition of intestinal
secretion and gut motility [10]. The mechanism of pancreatic
injury is thought to be by two different mechanisms. A study
on 8 healthy people showed that intraduodenal output of
amylase decreases after loperamide ingestion [6]. Being an
opiate it probably causes a spasm at the sphincter of Oddi in
a similar way to morphine. A study on 6 healthy people has
shown that loperamide causes dose-dependent inhibition of
pancreatic polypeptide release mediated by vagal-cholinergic
pathways [10]. The pancreatic polypeptide suppresses the
secretion from exocrine pancreas, and it has been proposed
that it most likely increases exocrine pancreas secretion [9].
In summary, the current case presented is the first one
published in English on loperamide associated pancreatitis
not associated with overdose. Thus, it seems likely that lop-
eramide in therapeutic doses can lead to clinically important
pancreatitis with inflammatory changes seen in the pancreas
on imaging studies.
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